Lotus Pharmaceuticals, Inc.
Period Ending Dec 31, 2010
Total Revenue 72,697
Cost of Revenue 32,916
Gross Profit 39,780
Operating Expenses
Research and Development 87
Sales, General and Admin. 18,409
Non-Recurring Items 6,763
Other -
Operating Income 14,522
Income From Continuing Operations
Add'l Income/Expense Items 735
Earnings Before Interest and Tax 15,258
Interest Expense 613
Earnings Before Tax 14,645
Income Tax 220
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 14,425
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 14,425
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 14,425